the beckman institute is right there on campus. or at least one of there campuses
i wouldnt be surprised if someone wants it analyzed
and i would bet pestell would like to get his hands on some tissue samples
the big thing they are going to want is pdl1 upreg change on camls.
that what predicts ici response. tissue cps doesnt correlate well.
i think creatv assays are more important eventually than ctdna for determining rollover etc
but ctdna for the backbone/leron portion is big and caught pashtoons interest first.
there are several including a different leronlimab specific one here:
https://creatvbio.com/posters
they have a combined cydy/briacell poster at next esmo here:
4506P - Monitoring Circulating Cancer Associated Macrophage-like Cell PD-L1 Predicts Clinical Outcomes in Metastatic Breast Cancer Treated with Immune Checkpoint Inhibitors
Presentation Number
4506P
Speakers
Sonia Muthuraj (New Brunswick, United States of America)
Authors
Sonia Muthuraj (New Brunswick, United States of America) Daniel L. Adams (Rockville, United States of America) Massimo Cristofanilli (New York, United States of America) Carolina Reduzzi (New York, United States of America) William V. Williams (Philadelphia, United States of America) Giuseppe Del Priore (Atlanta, United States of America) Blaise Bayer (Philadelphia, United States of America) Cha-mei Tang (Rockville, United States of America) Richard G. Pestell (Philadelphia, United States of America) Jacob P. Lalezari (Vancouver, United States of America) Joseph Meidling (Vancouver, United States of America) Saranya Chumsri (Jacksonville, United States of America)
Date
Fri, 23.10.2026
Time
15:15 - 16:00
the below poster is briacell
Monitoring PD-L1 in Tumor Macrophage Fusion Cells in Blood Identifies High PD-L1 Checkpoint Inhibitor Responses in Metastatic Breast Cancer
https://static1.squarespace.com/static/5bbbe3...t+1025.pdf